Related references
Note: Only part of the references are listed.Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives
Oskar Ciesielski et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2022)
Peptidylarginine Deiminase and Alzheimer's Disease
Lai Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
Tania Colasanti et al.
CELLS (2022)
Virtual Screening and In vitro Evaluation Identify Methotrexate and Testosterone are Inhibitors of Protein Arginine Deiminase 4
Sofia Ruiz-Hernandez et al.
ARCHIVES OF MEDICAL RESEARCH (2022)
A Novel Selective Inhibitor JBI-589 Targets PAD4-Mediated Neutrophil Migration to Suppress Tumor Progression
Hui Deng et al.
CANCER RESEARCH (2022)
Targeting citrullination in autoimmunity: insights learned from preclinical mouse models
Ylke Bruggeman et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2021)
Anti-cyclic citrullinated peptide antibody (ACPA) and Rheumatoid arthritis: Clinical relevance
Karthikeyan. P. Iyengar et al.
Journal of Clinical Orthopaedics and Trauma (2021)
In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives
M. V. K. Reddy et al.
ENVIRONMENTAL RESEARCH (2021)
Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis
M. K. Jonsson et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2020)
Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer
Miguel Beato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease
Marco Sancandi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets
Ashley M. Curran et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Characterizing basal-like triple negative breast cancer using gene expression analysis: A data mining approach
Amir Hassan Zadeh et al.
EXPERT SYSTEMS WITH APPLICATIONS (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Marine bromophenols as an effective inhibitor of virulent proteins (peptidyl arginine deiminase, gingipain R and hemagglutinin A) in Porphyromas gingivalis
Chikoo Cherian et al.
ARCHIVES OF ORAL BIOLOGY (2019)
Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor
Ardita Aliko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes
Valerie R. Wiersma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells
Fujun Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Myelin Basic Protein Citrullination, a Hallmark of Central Nervous System Demyelination, Assessed by Novel Monoclonal Antibodies in Prion Diseases
Byungki Jang et al.
MOLECULAR NEUROBIOLOGY (2018)
Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor
Caroline Chandra Tjin et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7 dependent lupus
Yudong Liu et al.
JCI INSIGHT (2018)
PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis
Sindhu Koushik et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
NETosis: At the crossroads of rheumatoid arthritis, lupus, and vasculitis
Jean-Marie Berthelot et al.
JOINT BONE SPINE (2017)
Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors
Wei Guo et al.
ONCOTARGETS AND THERAPY (2017)
Activation of Peptidylarginine Deiminase in the Salivary Glands of Balb/c Mice Drives the Citrullination of Ro and La Ribonucleoproteins
Mayra Rodriguez-Rodriguez et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling
Hao Qin et al.
CANCER LETTERS (2017)
Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis
V. C. Willis et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis
Andrea Seaman et al.
AUTOIMMUNITY REVIEWS (2016)
Peptidyl Arginine Deiminases and Neurodegenerative Diseases
R. Tu et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase
Dres Damgaard et al.
ARTHRITIS RESEARCH & THERAPY (2016)
ATF4 Gene Network Mediates Cellular Response to the Anticancer PAD Inhibitor YW3-56 in Triple-Negative Breast Cancer Cells
Shu Wang et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation
Huw D. Lewis et al.
NATURE CHEMICAL BIOLOGY (2015)
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
Sharad Kholia et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation
Christina J. Dreyton et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis
Jason S. Knight et al.
CIRCULATION RESEARCH (2014)
Citrullination Alters Immunomodulatory Function of LL-37 Essential for Prevention of Endotoxin-Induced Sepsis
Joanna Koziel et al.
JOURNAL OF IMMUNOLOGY (2014)
Peptidylariginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates
Sigrun Lange et al.
JOURNAL OF NEUROCHEMISTRY (2014)
Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury
Ahrom Ham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
Shu Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
The protein arginine deiminases: Structure, function, inhibition, and disease
Kevin L. Bicker et al.
BIOPOLYMERS (2013)
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis
Mario A. Moscarello et al.
DISEASE MODELS & MECHANISMS (2013)
Neuronal PAD4 expression and protein citrullination: Possible role in production of autoantibodies associated with neurodegenerative disease
Nimish K. Acharya et al.
JOURNAL OF AUTOIMMUNITY (2012)
Neutrophils in multiple sclerosis are characterized by a primed phenotype
Matthias Naegele et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Potential Role for PAD2 in Gene Regulation in Breast Cancer Cells
Brian D. Cherrington et al.
PLOS ONE (2012)
Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation
Xuesen Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Activation of PAD4 in NET formation
Amanda S. Rohrbach et al.
FRONTIERS IN IMMUNOLOGY (2012)
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor
Alexander A. Chumanevich et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra
Anthony P. Nicholas
NEUROSCIENCE LETTERS (2011)
Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease
Byungki Jang et al.
ACTA NEUROPATHOLOGICA (2010)
Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation
Yanming Wang et al.
JOURNAL OF CELL BIOLOGY (2009)
Increased expression of PAD2 after repeated intracerebroventricular infusions of soluble Aβ25-35 in the Alzheimer's disease model rat brain: Effect of memantine
Mohammad Arif et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2009)
Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility
G. Esposito et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: A role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation
Fabrizio G. Mastronardi et al.
JOURNAL OF NEUROSCIENCE (2006)
Inhibitors and inactivators of protein arginine deiminase 4: Functional and structural characterization
Yuan Luo et al.
BIOCHEMISTRY (2006)
Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice
Reinout Raijmakers et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
A fluoroacetamidine-based inactivator of protein arginine deiminase 4: Design, synthesis, and in vitro and in vivo evaluation
Y Luo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data
Anita Grigoriadis et al.
BREAST CANCER RESEARCH (2006)
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease
A Ishigami et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Synergistic interactions of lipids and myelin basic protein
YF Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Histone deimination antagonizes arginine methylation
GL Cuthbert et al.
CELL (2004)
Structural basis for Ca2+-induced activation of human PAD4
K Arita et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Human PAD4 regulates histone arginine methylation levels via demethylimination
Y Wang et al.
SCIENCE (2004)
Peptidylarginine deiminase: a candidate factor in demyelinating disease
MA Moscarello et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Share Paper
